摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

norcordrastine | 51491-38-4

中文名称
——
中文别名
——
英文名称
norcordrastine
英文别名
(RS)-3-((Ξ)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinolin-1-yl)-6,7-dimethoxy-3H-isobenzofuran-1-one;3-(6,7-dimethoxy-1,2,3,4-tetrahydro-[1]isoquinolyl)-6,7-dimethoxy-phthalide;3-(6,7-Dimethoxy-1,2,3,4-tetrahydro-[1]isochinolyl)-6,7-dimethoxy-phthalid;3-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)-6,7-dimethoxy-3H-2-benzofuran-1-one
norcordrastine化学式
CAS
51491-38-4
化学式
C21H23NO6
mdl
——
分子量
385.417
InChiKey
HROXDNNKVQMKNH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    28
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    75.2
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    聚合甲醛norcordrastine甲酸 为溶剂, 反应 2.0h, 生成 Cordrastine I
    参考文献:
    名称:
    Clarke, Stuart I.; Kasum, Bruno; Prager, Rolf H., Australian Journal of Chemistry, 1983, vol. 36, # 12, p. 2493 - 2498
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Decarboxylation of phthalidecarboxylic acids in the presence of imines - a facile route to isoindolo[1,2-b][3]benzazepin-5-ones and phthalideisoquinolines
    摘要:
    DOI:
    10.1016/s0040-4039(00)85413-1
点击查看最新优质反应信息

文献信息

  • The Synthesis of (±)-Cordrastine. A New Route to the Phthalideisoquinoline System
    作者:V. Smula、N. E. Cundasawmy、H. L. Holland、D. B. MacLean
    DOI:10.1139/v73-490
    日期:1973.10.1

    The phthalideisoquinoline system has been synthesized from substituted 2-phenyl-1,3-indandiones as starting materials. The key step in the synthesis is the rearrangement of the spirobenzylisoquinoline ring system to the phthalideisoquinoline system. The diastereomeric cordrastines, I and II, have been synthesized by this method and their relative configurations have been established by comparison of their p.m.r. spectra with those of phthalideisoquinoline alkaloids of known configuration.

    苯甲酮异喹啉系统已经从取代的2-苯基-1,3-酮合成为起始原料。合成中的关键步骤是将螺苯基异喹啉环系统重新排列为苯甲酮异喹啉系统。通过这种方法合成了异构的cordrastines,I和II,并通过比较它们的p.m.r.光谱与已知构型的苯甲酮异喹啉生物碱的光谱来确定它们的相对构型。
  • CHIEFARI, JOHN;JANOWSKI, WIT K.;PRAGER, ROLF H., AUSTRAL. J. CHEM., 42,(1989) N, C. 49-60
    作者:CHIEFARI, JOHN、JANOWSKI, WIT K.、PRAGER, ROLF H.
    DOI:——
    日期:——
  • [EN] TETRAHYDROISOQUINOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF<br/>[FR] COMPOSÉS DE TÉTRAHYDROISOQUINOLINE, PROCÉDÉS DE PRÉPARATION ASSOCIÉS ET UTILISATION ASSOCIÉE
    申请人:UNIV SHENYANG PHARMACEUTICAL
    公开号:WO2011075957A1
    公开(公告)日:2011-06-30
    Tetrahydroisoquinoline compounds, synthesis methods and uses in inhibiting tumor cell proliferation are disclosed. A series of novel tetrahydroisoquinoline compounds (I) are synthesized by modifying the structure of natural (-)-α-(1R,9S)-narcotine. Through screening anti-tumor activity in vitro, it is shown that the compounds have a significant effect on inhibiting tumor cell proliferation and can be further developed into novel anti-tumor medicaments.
查看更多

同类化合物

阿托喹啉 那可汀 那可丁N-氧化物 诺司卡品 盐酸盐 水合物 细果角茴香碱 紫堇明 盐酸那可丁一水合物 盐酸诺格考平 盐酸白毛莨碱 曲托喹啉 山缘草定碱 咖喏定 北美黄连碱 [S-(R*,R*)]-6,7-二甲氧基-3-(5,6,7,8-四氢-4-羟基-6-甲基-1,3-二氧杂环戊并[4,5-g]异喹啉-5-基)苯酞 [6S,(+)]-6-[(1S)-1,2,3,4-四氢-6,7-二甲氧基-2-甲基异喹啉-1-基]呋喃并[3,4-e]-1,3-苯并二氧戊环-8(6H)-酮 7-氨基-4,5,6-三乙氧基-3-(6,7,8-三甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基)-3H-2-苯并呋喃-1-酮 7-O-去甲基alpha-那可丁 6,7-二甲氧基-3-[(5R)-4-甲氧基-6-甲基-7,8-二氢-5H-[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-3H-2-苯并呋喃-1-酮 3-异喹啉-1-基-3H-2-苯并呋喃-1-酮 (3S)-6,7-二甲氧基-3-[(5S)-6-甲基-5,6,7,8-四氢[1,3]二氧杂环戊并[4,5-g]异喹啉-5-基]-2-苯并呋喃-1(3H)-酮 (3S)-3-[(1R)-6,7-二羟基-8-甲氧基-2-甲基-3,4-二氢-1H-异喹啉-1-基]-6,7-二甲氧基-3H-2-苯并呋喃-1-酮 (-)-荷苞牡丹碱甲溴化物 (-)-荷苞牡丹碱 (-)-荷包牡丹碱甲碘化物 (-)-荷包牡丹碱甲溴化物 (-)-荷包牡丹碱甲氯化物 (-)-紫堇明 (+)-荷苞牡丹碱甲氯化物 (+)-荷包牡丹碱 8-Isopentyl-narcotolin 8-<4-Chlor-benzyl>-narcotolin (R)-5-((R)-4,5-dimethoxy-3-oxo-phthalan-1-yl)-4-methoxy-6,6-dimethyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolinium; iodide 8-Allylnarkotolin 8-p-Nitrobenzylnarkotolin 2-(thiazolidin-3-yl)ethyl (E)-6-[1,3-dihydro-4-(N-(trifluoroacetyl)-N-isopropyl)amino-6-methoxy-7-methyl-3-oxoisobenzofuran-5-yl]-4-methyl-4-hexenoate 2-[5-(4,5-Dimethoxy-3-oxo-1,3-dihydro-isobenzofuran-1-yl)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-4-yloxy]-N-(4-ethoxy-phenyl)-acetamide 8-Narcotolinessigsaeureethylester 2-[5-(4,5-Dimethoxy-3-oxo-1,3-dihydro-isobenzofuran-1-yl)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-4-yloxy]-N-(4-sulfamoyl-phenyl)-acetamide 6-(6',7'-diacetoxy-2'-methyl-1',2',3',4'-tetrahydroisoquinolin-1'-yl)furo<3,4-e>-1,3-benzodioxol-8(6H)-one hydrobromide 6,7-dimethoxy-3(7-methoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)isobenzofuran-1(3H)-one 5-((R)-4,5-Dimethoxy-3-oxo-1,3-dihydro-isobenzofuran-1-yl)-6-methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinolin-6-ium (+/-)-erythro-1-<1'-(4',5'-dimethoxyphthalidyl)>-2-methyl-1,2,3,4-tetrahydroisoquinoline 6-(6',7'-dihydroxy-2'-methyl-1',2',3',4'-tetrahydroisoquinolin-1'-yl)furo<3,4-e>-1,3-benzodioxol-8(6H)-one hydrobromide 4-{2-[5-(4,5-Dimethoxy-3-oxo-1,3-dihydro-isobenzofuran-1-yl)-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-4-yloxy]-acetylamino}-benzoic acid ethyl ester Corledin-acetat (-)-α-hydrastine; hydrochloride N-Aminonarcotiniumion 3d-β-Narcotin rac-2,3;10,11-bis-methanediyldioxy-16ξ-methyl-16ξ-oxy-rheadan-8-one (1R,5R)-8,9,18,19-tetramethoxy-3-oxa-13-azapentacyclo[11.8.0.01,5.06,11.016,21]henicosa-6,8,10,16,18,20-hexaene-4,12-dione